Turk İlaç ve Serum

Türk İlaç ve Serum Sanayi is a prominent Turkish pharmaceutical company specializing in the production of intravenous (IV) solutions, vaccines, and generic medications. Headquartered in Ankara, the company operates a large-scale GMP-certified manufacturing facility and serves as a major supplier to the Turkish State Supply Office (DMO). Their product portfolio includes a wide range of parenteral solutions, dialysis concentrates, and blood products essential for hospital care. Notably, the company has established strategic international partnerships for the local production and distribution of vaccines, including the Hepatitis B vaccine in collaboration with LG Chem. Türk İlaç is publicly traded on the Borsa Istanbul and plays a critical role in strengthening Turkey's domestic healthcare and pharmaceutical manufacturing self-sufficiency.